Followers | 227 |
Posts | 13143 |
Boards Moderated | 0 |
Alias Born | 09/26/2011 |
Thursday, October 05, 2017 6:13:28 PM
FORT LAUDERDALE, FL--(Marketwired - Sep 26, 2017) - Real Brands, Inc. (OTC PINK: RLBD) is pleased to announce today that they have acquired the CBD Pharmacy trademark™ plus four (4) US utility patents for the manufacture of consumable legal cannabis and hemp products as defined by the states on a state by state basis. In addition RLBD has also agreed to acquire four (4) Colorado trademarks for use in legal cannabis and hemp products.
Currently, 28 states and Washington, DC have legalized medicinal and/or recreational cannabis use and the industry is already estimated to be a multiple billion dollar industry, making the timing for brand building optimal. As consumers become increasingly aware of the medicinal benefits of Cannabis and CBD's, the industry is expected to continue growing over 20% annually through 2021.*
"Since signing the binding letter of intent in May of this year we have been focusing on the CBD Pharmacy line and we have finalized the new CBD Pharmacy™ logo and packaging design," said Jerry Pearring, CEO of Real Brands, Inc. "We anticipate our licensees will introduce the CBD Pharmacy line of Vape Cartridges into several states in the coming months, while we simultaneously develop new products for the CBD Pharmacy line and explore opportunities for all of our trademarks and utility patents."
The four (4) additional Colorado trademarks are:
Marijuana Cigarettes
Cannabis Cigarettes
Hemp Cigarettes
Cannabis Smoke Tobacco
The four (4) utilities patents include:
An Inhaler for the consumption of Cannabinoids
Cannabis Infused Chewing Composition
A Method of Manufacturing a Smokable Cannabis Product
Cannabis Smokeless Tobacco
About Real Brands
Real Brands, Inc. (RLBD) is a publicly held brand building company active in the legal cannabis and hemp industry. The Company recently acquired the Omega Hemp Water™ trademark from Alkame Holdings, Inc.
*Source: Arcview Group
Safe Harbor Statement
Any statements in this press release that relate to Real Brands' expectations with regard to the future impact on its results are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The results anticipated by any or all of these forward-looking statements might not occur. Real Brands undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in Real Brands' plans or expectations.
Interviews and imagery available upon request
For additional information contact:
Jerry Pearring
jerry@realbrandsusa.com
954-270-5309
Recent RLBD News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:25:53 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 05:20:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:15:35 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM